Assistance Publique - Hôpitaux de Paris: Rare Diseases trials
The registry lists 10 Rare Diseases studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 3 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in FranceNot yet recruitingNCT07851844
- Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA CenterRecruitingNCT07205861
- Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology PatientsRecruitingNCT07147465
- Announcement of Rare Metabolic Diseases in Systematic Newborn Screening: the Phenylketonuria Experience.RecruitingNCT06289348
- Oral Health Related Quality of Life of Patients With Rare Diseases: a Qualitative ApproachCompletedNCT05070988
- Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune DiseasesStatus unknownNCT05026892
- Medication Reconciliation in Pulmonary HypertensionCompletedNCT04744584
- Therapeutic Anticoagulation Strategy for Acute Chest SyndromeCompletedNCT02580773Phase 3
- Pregnancy and Medically Assisted Conception in Rare DiseasesWithdrawnNCT02450396
- New Phototherapy Device to Treat Patients With Crigler-Najjar DiseaseStatus unknownNCT02356978Not applicable